TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/31/2024
Back to search
Official data from USPTO
MODERNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
04/03/2025
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
05/22/2020
Registration date
01/16/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/16/2024
Last transaction
04/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/30/2013
First use in commerce
05/30/2013
Drawing code
3
Owner type
03
Owner location
CAMBRIDGE, MA
Examiner
RICHARDS, LESLIE
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "MODERNA" in red above a blue dotted line.
Holders and representatives
Holders
ModernaTx, Inc.
ModernaTx, Inc.
Representatives
John Francis Ward Moderna
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
biochemicalsprotein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivoex vivoon vivo or in vitro scientific research and medical research; biochemicalsprotein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancersinflammatory disordersimmunoregulatory disordersmetabolic disorders and infectious disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use; chemicals for use in biotherapeuticstherapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use
Class 5
medicalbiological and pharmaceutical preparations for scientificresearchmedicalpharmaceutical usepreparations for treating cancersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disorders; medicalbiological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseasescancersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivoex vivoon vivo delivery to cell sites; medical diagnostic reagents
Class 42
scientific research in the fields of pharmaceuticalsvaccinesmedicinebiologicsbiotherapeuticstherapeutics; designengineeringresearchdevelopment and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids
Publications
History of USPTO decisions and trademark events.
58 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/31/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/31/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/31/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/31/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/22/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/16/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/16/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/13/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/06/2023
IUAF
USE AMENDMENT FILED
11/01/2023
EISU
TEAS STATEMENT OF USE RECEIVED
11/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/30/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/30/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/25/2023
EX5G
SOU EXTENSION 5 GRANTED
04/24/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/24/2023
EXT5
SOU EXTENSION 5 FILED
04/18/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/18/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2022
EX4G
SOU EXTENSION 4 GRANTED
10/30/2022
EXT4
SOU EXTENSION 4 FILED
10/30/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/30/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/05/2022
EX3G
SOU EXTENSION 3 GRANTED
05/03/2022
EXT3
SOU EXTENSION 3 FILED
05/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/28/2021
EX2G
SOU EXTENSION 2 GRANTED
10/26/2021
EXT2
SOU EXTENSION 2 FILED
10/26/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/28/2021
EX1G
SOU EXTENSION 1 GRANTED
04/26/2021
EXT1
SOU EXTENSION 1 FILED
04/26/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/26/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/31/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/31/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/31/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/31/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/31/2020
DOCK
ASSIGNED TO EXAMINER
07/31/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2020
NWAP
NEW APPLICATION ENTERED
05/26/2020
Continuous trademark protection
Get notified about every new filing that threatens MODERNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.